[1]陆婷婷,柯玲玲,汤磊磊,等.淫羊藿苷靶向肿瘤免疫调节及其抗肿瘤作用机制研究概况[J].甘肃中医药大学学报,2018,35(06):82-85.[doi:10.16841/j.issn1003-8450.2018.06.18]
 LU Tingting,KE Lingling,TANG Leilei,et al.Study on the icariin targeting tumor immunomodulation and its anti-tumor mechanism[J].Journal of Gansu University of Chinese Medicine,2018,35(06):82-85.[doi:10.16841/j.issn1003-8450.2018.06.18]
点击复制

淫羊藿苷靶向肿瘤免疫调节及其抗肿瘤作用机制研究概况
分享到:

《甘肃中医药大学学报》[ISSN:1003-8450/CN:62-1062/R]

卷:
35卷
期数:
2018年06期
页码:
82-85
栏目:
文献综述
出版日期:
2018-12-25

文章信息/Info

Title:
Study on the icariin targeting tumor immunomodulation and its anti-tumor mechanism
作者:
陆婷婷1 柯玲玲2 汤磊磊3 王立宇1
1. 安徽中医药大学中西医结合学院, 安徽 合肥 230031;
2. 南京中医药大学第一临床医学院, 江苏 南京 210023;
3. 安徽中医药大学第一附属医院乳腺外科, 安徽 合肥 230031
Author(s):
LU Tingting1 KE Lingling2 TANG Leilei3 WANG Liyu1
1. College of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, Anhui, 230031, China;
2. The First Clinical Medical School, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China;
3. Breast Surgery, the First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, 230031, China
关键词:
淫羊藿苷抗肿瘤免疫调节综述
Keywords:
icariin (ICA)anti-tumortumor immunomodulationsummary
分类号:
R285
DOI:
10.16841/j.issn1003-8450.2018.06.18
摘要:
从调控免疫器官、免疫细胞相关功能,增强免疫细胞因子活性,抑制肿瘤细胞生长、增殖及肿瘤血管的形成,诱导肿瘤细胞凋亡,改变肿瘤细胞的周期分布,阻断炎症信号通路传导及抑制端粒酶活性等方面对近10年来淫羊藿苷抗肿瘤的作用研究概况进行总结,为淫羊藿苷治疗肿瘤提供理论依据。
Abstract:
This paper summarizes the anti-tumor effects of icarrin (ICA) from the aspects of regulating the related functions of the immune organs and immune cells, enhancing the activity of immune cell cytokines, inhibiting the growth, proliferation of tumor cells and formation of tumor vessels, inducing tumor cell differentiation and apoptosis, changing the cycle distribution of tumor cells, blocking the transmission of inflammatory signaling pathway and inhibiting telomerase activity in the last decade, which provides the theoretical basis for the treatment of tumors with icariin.

参考文献/References:

[1] MA H, HE X, YANG Y, et al.The genus epimedium:an ethnophar-macological and phytochemical review[J].J Ethnopharmacol, 2011, 134(3):519-541.
[2] 陈发菊, 金凤, 吴芹, 等.淫羊藿苷对SAMP8小鼠肝脏、肾脏及胸腺的保护作用[J].遵义医学院学报, 2016, 39(2):150-153.
[3] 袁嘉瑞, 汪春飞, 宋捷, 等.淫羊藿醇提物抑制肺癌生长及调节免疫作用研究[J].中国中药杂志, 2016, 41(1):112-117.
[4] 赵连梅, 纪昕, 潘晓明, 等.淫羊藿苷(ICA)对化疗后免疫抑制小鼠的免疫促进作用[J].中医中药与免疫, 2009, 25(12):1092-1099.
[5] 潘晓明.淫羊藿苷体内外免疫调节作用的实验研究[D].石家庄:河北医科大学, 2010.
[6] 滕菲, 曾耀英, 黄秀艳, 等.淫羊藿苷对小鼠T淋巴细胞体外活化和增殖的影响[J].免疫学杂志, 2008, 24(6):613-617.
[7] 单保恩, 潘晓明, 赵连梅, 等.淫羊藿苷促进脐血来源树突状细胞的分化与成熟[J].中国肿瘤生物治疗杂志, 2009, 16(4):325-330.
[8] LAI X, YE Y, SUN C, et al.Icaritin exhibits anti-inflammatory effects in the mouse peritoneal macrophages and peritonitis model[J].Int Immunopharmacol, 2013, 16(1):41-49.
[9] Bruunsgaard H.The clinical impact of systemic low-level inflammation in elderly populations with special reference to Cardiovascular disease dementia and mortality[J].Dan Med Bull, 2006, 53:285-309.
[10] Larbi A, Franceschi C, Mazzatti D, et al.Aging of the immune system as a prognostic factor for human longevity[J].Physiology (Bethesda), 2008, 23:64-74.
[11] Licastro F, Candore G, Lio D, et al.Innate immunity and inflammation in ageing a key for understanding age-related diseases[J].Immun Ageing, 2005, 2(8):1-14.
[12] 罗娟, 戢艳琼, 谭艳, 等.淫羊藿苷对ox-LDL诱导巨噬细胞凋亡的作用及其机制的研究[J].中国新药杂志, 2016, 25(23):2701-2706.
[13] 赵连梅, 纪昕, 单保恩, 等.淫羊藿苷对化疗后小鼠骨髓和细胞免疫抑制作用的影响[J].细胞分子与免疫学杂志, 2010, 26(10):976-979.
[14] 吴金峰, 董竞成, 徐长青, 等.淫羊藿苷拮抗脂多糖炎症模型的体内和体外研究[J].中国中西医结合杂志, 2009, 29(4):330-333.
[15] 郑传铭, 葛明华, 王佳峰, 等.淫羊藿苷促进活性氧表达诱导甲状腺癌B-CPAP细胞凋亡的研究[J].中国癌症杂志, 2016, 26(5):388-393.
[16] 王伟, 张涛.5种中药黄酮对血管平滑肌细胞凋亡的交互作用[J].北京中医药大学学报, 2000, 23(4):18-21.
[17] Mattias Carlsten, Richard W Childs.Genetic manipulation of NK cells for cancer immunotherapy:techniques and clinical implications[J].Front Inmunol, 2015, 6:266.
[18] 高明, 黎玮.淫羊藿苷对人膀胱癌T24细胞抑制作用的体外研究[D].石家庄:河北医科大学, 2010.
[19] WANG Z, ZHANG H, DAI L, et al.Arsenic trioxide and icariin show synergistic anti-leukemic activity[J].Cell Biochem Biophy, 2015, 73(1):1-7.
[20] YANG C, TAO S, WU J Z, et al.Icariin intervenes in cardiac inflammaging through upregulation of SIRT6 enzyme activity and inhibition of the NF-Kappa B pathway[J].Biomed Res Int, 2015, 6(20):315-329.
[21] 付晓霞, 罗云梅, 刘娟, 等.淫羊藿苷对CX3CL1诱导的单核细胞向人脐静脉内皮细胞迁移和黏附的影响及机制[J].遵义医学院学报, 2017, 40(1):59-63.
[22] 宋飞, 高素君.淫羊藿苷对NB4白血病细胞株增殖和凋亡的影响及其作用机制[J].吉林大学学报, 2015, 41(6):1181-1185.
[23] Naeyer A, Pocock V, Milligan S, et al.Estrogenic activity of a polyphenolic extract of the leaves of Epimedium brevicornum[J].Fitoterapia, 2005, 76(1):35-40.
[24] LIU J, LOU Y J.Determination of icariin and metabolitesin rat serum by capillary zone electrophoresis:rat pharmacokinetic studies after administration of icariin[J].J Pharm Biomed Anal, 2004, 36(2):365-370.
[25] 古玉梅, 徐长青, 洪铭范, 等.淫羊藿苷对实验性自身免疫性脑脊髓炎小鼠的治疗作用[J].广东药学院学报, 2015, 31(5):617-620.
[26] 汪海东, 夏世金, 陈颂春, 等.淫羊藿苷经NF-κB信号通路干预大鼠免疫衰老的作用及机制[J].中国老年学杂志, 2010, 30(20):2938-2941.
[27] ZHANG Y, WEI Y, ZHU Z, et al.Icariin enhances radio-sensitivity of colorectal cancer cells by suppressing NF-κB activity[J].Cell Biochem Biophys, 2014, 69(2):303-310.
[28] ZHANG D C, LIU J L, DING Y B, et al.Icariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-κB[J].Acta Pharmacol Sin, 2013, 34(2):301-308.
[29] TONG J S, ZHANG Q H, HUANG X, et al.Icaritin causes sustained ERK1/2 activation and induces apoptosis in human endometrial cancer cells[J].PLoS One, 2011, 6(3):167-168.
[30] 叶玉荷, 胡芳华, 邹佳萍.淫羊藿苷在体内外对血管生成的抑制作用[J].中国医学科学院学报, 2015, 6(3):264-268.
[31] 张玲, 王芸, 毛海婷, 等.淫羊藿苷抑制肿瘤细胞端粒酶活性及其调节机制的研究[J].中国免疫学杂志, 2002, 18(3):191-196.
[32] 葛林阜, 董政军, 姜国胜, 等.淫羊藿苷对急性早幼粒白血病细胞端粒酶活性的影响[J].中国肿瘤生物治疗杂志, 2002, 9(1):36-38.

相似文献/References:

[1]刘玉,陈彻,韩丽,等.三氧化二砷基于促分裂原活化的蛋白激酶信号通路的抗肿瘤作用研究进展[J].甘肃中医药大学学报,2015,32(06):78.
[2]吴祖锋,袁垒,吴风晴,等.淫羊藿苷对骨质疏松症模型大鼠OPG/RANKL/RANK轴系统影响的实验研究[J].甘肃中医药大学学报,2016,33(03):4.[doi:10.16841/j.issn1003-8450.2016.03.02]
 WU Zufeng,YUAN Lei,WU Fengqing,et al.Effect of icariin on OPG/RANKL/RANK axial system in model rats with osteoporosis[J].Journal of Gansu University of Chinese Medicine,2016,33(06):4.[doi:10.16841/j.issn1003-8450.2016.03.02]
[3]刘炫斯,谢玲玲.淫羊藿苷对MSCs表达α-MHC和β-MHC的诱导条件研究[J].甘肃中医药大学学报,2012,(02):52.
 Liu Xuansi,Xie Lingling.Study of the induction condition of ICA on α-MHC and β-MHC produced by MSCs[J].Journal of Gansu University of Chinese Medicine,2012,(06):52.
[4]刘宗权,宋敏,蒋宜伟,等.淫羊藿苷抗骨质疏松对去势大鼠PINP,NTx影响的实验研究[J].甘肃中医药大学学报,2014,31(03):4.
[5]白璧辉,苏凯堂,宋永嘉,等.PI对肿瘤细胞抑制作用的研究[J].甘肃中医药大学学报,2014,31(04):11.
[6]李兴玉,丁慧蓉.气血康抗肿瘤的体外实验研究[J].甘肃中医药大学学报,1996,(01):18.
[7]边应孝,王志凡.佛菇抑瘤煎的体内抗肿瘤作用[J].甘肃中医药大学学报,1998,(02):30.
 Bian Yingxiao,Wang Zhifan.Antitumor effect of Fuguyil iujian(FGJ) in vivo[J].Journal of Gansu University of Chinese Medicine,1998,(06):30.
[8]楚惠媛,陈彻.以端粒酶为靶目标的抗肿瘤研究近况[J].甘肃中医药大学学报,2003,(03):55.
[9]余晓晖,侯嘉,赵磊,等.甘肃不同产地淫羊藿中总黄酮和淫羊藿苷含量测定[J].甘肃中医药大学学报,2014,31(01):13.
 Yu Xiaohui,Hou Jia,Zhao Lei,et al.The content measure of total flavone and epimedium lan in Herba Epimedium get from different area of Gansu Province[J].Journal of Gansu University of Chinese Medicine,2014,31(06):13.
[10]刘东玲,支德娟,白彦丽,等.秀丽隐杆线虫作为Ras/MAPK信号通路的抗肿瘤药物筛选模型研究[J].甘肃中医药大学学报,2018,35(02):1.[doi:10.16841/j.issn1003-8450.2018.02.01]
 LIU Dongling,ZHI Dejuan,BAI Yanli,et al.Using Caenorhabditis elegans is to study the antitumor drug screening model of the Ras/MAPK signaling pathway[J].Journal of Gansu University of Chinese Medicine,2018,35(06):1.[doi:10.16841/j.issn1003-8450.2018.02.01]

备注/Memo

备注/Memo:
收稿日期:2018-04-19。
基金项目:2016年度安徽省高等学校自然科学研究重点项目(KJ2016A399);2014年大学生创新创业训练项目(2014104);2012年度安徽中医学院自然科学研究基金项目(2012zr002)。
作者简介:陆婷婷(1983-),女,讲师,在读博士研究生。研究方向:中药活性成分抗肿瘤作用。
更新日期/Last Update: 1900-01-01